Illinois Chapter of AACE 8th Annual Meeting
Welcome, and thank you for attending the Illinois-AACE 8th Annual Meeting.
The Illinois Chapter of AACE program committee has worked very hard to provide a relevant activity for the practicing clinical physician and other healthcare providers seeking education with an emphasis in endocrine disease.
This program has been planned to provide pertinent scientific and clinical information to help you achieve the best solutions in the diagnosis and therapeutic management of patients presenting with endocrine disease. Attendees will obtain updates in not only common and uncommon endocrine disorders, but also newer treatment modalities.
Providing exceptional patient care requires continuing high quality education. The American Association of Clinical Endocrinologists (AACE) was founded in 1991 by a visionary group of leaders to serve as the active voice for clinical endocrinologists. The impetus behind AACE's efforts has always been quality and cost-effective patient care for those with endocrine diseases and disorders. We hope that you will find this program of great value to you in your practice.
Endocrinologists, physicians, advanced practice clinicians and other health care professionals in Illinois who practice, or are interested in, the treatment of endocrine disease.
- After participating in a pre-meeting assessment tool, attendees will be able to recognize areas of potential shortcoming and strive to improve knowledge and consequential healthcare practices.
- What is the role of US in follow up of thyroid cancer?
- What is the value of TG in detecting thyroid cancer?
- How to manage small, recurrent neck PTC?
- Discuss update on cardiovascular risk and diabetes
- Discuss update on Am Diabetes Association guidelines and blood pressure management
- Discuss update on kidney disease progression from diabetes
- Understand the route from genetic discovery to biological insight to new therapies
- Assess the potential impact of different types of genetic information on individual clinical management
- Recognize different types of genetic methods for research and clinical practice
- Identify the clinical signs and symptoms of patients with pheochromocytoma
- Accurately diagnose pheochromocytoma and successfully prepare the patient for adrenal surgery
- Manage common postoperative findings in patients with pheochromocytoma and recommend long-term surveillance plan
- Articulate the impact a correct diagnosis of monogenic can have on treatment and management
- Identify specific genetic testing associated with monogenic diabetes diagnoses
- Identify other conditions, diagnoses and syndromes related to monogenic diabetes
- Attendees will be able to measure learning that occurred that will enable the use of new healthcare techniques and practices and to review or confirm existing care modalities.
LOYOLA UNIVERSITY CHICAGO
HEALTH SCIENCES CAMPUS / TOBIN HALL
2160 SOUTH 1ST AVENUE
MAYWOOD, IL 60153
Saturday, October 13, 2018
|7:00 – 7:45 AM|
Registration / Breakfast
|7:45 – 8:00 AM|
Opening Remarks / Pre-meeting Assessment
|8:05 – 8:45 AM|
Recurrent Thyroid Cancer: How to detect & when to treat
|8:50 – 9:30 AM|
Impact of Diabetes on Cardiorenal Outcomes
|9:35 – 10:15 AM|
Short- and Long-Term Impact of Genetics on Clinical Endocrinology
|10:20 – 10:50 AM|
|10:55 – 11:35 AM|
Diagnosis and Management of Pheochromocytoma
|11:40 – 12:20 PM|
The Importance of Making a Diagnosis: The case for Monogenic Diabetes
|12:25 – 1:10 PM|
Fellow Oral presentations / Lunch
|1:10 – 1:25 PM|
|1:25 – 1:40 PM|
Business Meeting / Adjournment
George Bakris, MD
Professor of Medicine
University of Chicago Medicine
Steven DeJong, MD
Professor and Vice Chairman of Surgery
Loyola University Medical Center
Hossein Gharib, MD
Joel Hirschhorn, MD, PhD
Chief, Division of Endocrinology, Concordia Professor of Pediatrics and Professor of Genetics
Boston Children's Hospital/Harvard Medical School
Louis Philipson, MD, PhD, FACP
James C. Tyree Professor and Director, Kovler Diabetes Center
UChicago Medicine Kovler Diabetes Center
Disclosure and Resolutions of Conflicts of Interest
The American Association of Clinical Endocrinologists remains strongly committed to providing the best available evidence-based clinical information to participants of this educational activity and requires an open disclosure of any potential conflict of interest identified by our faculty members. It is not the intent of the American Association of Clinical Endocrinologists to eliminate all situations of potential conflict of interest, but rather to enable those who are working with the American Association of Clinical Endocrinologists to recognize situations that may be subject to question by others. All disclosed conflicts of interest are reviewed by the educational activity course director/chair to ensure that such situations are properly evaluated and, if necessary, resolved. The American Association of Clinical Endocrinologists educational standards pertaining to conflict of interest are intended to maintain the professional autonomy of the clinical experts inherent in promoting a balanced presentation of science. Through our review process, all American Association of Clinical Endocrinologists CME activities are ensured of independent, objective, scientifically balanced presentations of information. Disclosure of any or no relationships will be made available for all educational activities. All faculty and planning committee members are required to disclose any financial relationships and will be listed accordingly at aace.com.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Association of Clinical Endocrinologists (AACE) and the Illinois Chapter of AACE. The American Association of Clinical Endocrinologists (AACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Association of Clinical Endocrinologists (AACE) designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 4.00 AMA
- 4.00 Attendance